Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the ...

Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings ...
Public Broadcasting Service (PBS)

A $400,000 payout after Maduro's capture put prediction markets in the spotlight. Here's how they work

The commercial use of prediction markets has skyrocketed in recent years, opening the door for people to wage their money on ...
Investing.com India

Day One Biopharmaceuticals stock soars after strong 2025 revenue forecast

Investing.com -- Day One Biopharmaceuticals (NASDAQ:DAWN) stock rose 19% Monday morning after the company announced preliminary 2025 net product revenue of $155.4 million for its OJEMDA drug, ...